Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wessel-aas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1980
Serum levels of mecillinam in patients with severely impaired renal functionP L Svarva, T Wessel-Aas
Arzneimittel-Forschung|January 1, 1985
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiencyO G Nilsen, T Wessel-Aas, F Walseth
Scandinavian Journal of Respiratory Diseases. Supplementum|January 1, 1970
Artificial ventilation in chronic pulmonary insufficiency. Indications and prognosisT Wessel-Aas, J R Vale, H E Hauge
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 1981
[Comparative study of labetolol and propranolol in patients with untreated hypertension]T Wessel-Aas, R A Walstad, K J Berg
Acta Medica Scandinavica|January 1, 1984
Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acidsT Wessel-Aas, J P Blomhoff, E Wirum, et al.
Acta Pharmacologica Et Toxicologica|March 1, 1985
The influence of sustained release theophylline therapy on free fatty acids in serumR A Walstad, K I Myhre, E Wirum, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Labetalol in the treatment of hypertension in patients with normal and impaired renal functionR A Walstad, K J Berg, T Wessel-Aas, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysisT E Wideröe, L C Smeby, O L Myking, et al.
Acta Medica Scandinavica|January 1, 1984
Toxicity of plasma from hemodialysis patients treated with heparin or prostacyclinT Wessel-Aas, K J Berg, T E Widerøe, et al.
Acta Medica Scandinavica|January 1, 1984
The effect of systemic heparinization on plasma lipoproteins and toxicity in patients on hemodialysis and continuous ambulatory peritoneal dialysisT Wessel-Aas, J P Blomhoff, T E Widerøe, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Infectious Diseases|January 1, 1980
Serum levels of mecillinam in patients with severely impaired renal functionP L Svarva, T Wessel-Aas
Arzneimittel-Forschung|January 1, 1985
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiencyO G Nilsen, T Wessel-Aas, F Walseth
Scandinavian Journal of Respiratory Diseases. Supplementum|January 1, 1970
Artificial ventilation in chronic pulmonary insufficiency. Indications and prognosisT Wessel-Aas, J R Vale, H E Hauge
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 1981
[Comparative study of labetolol and propranolol in patients with untreated hypertension]T Wessel-Aas, R A Walstad, K J Berg
Acta Medica Scandinavica|January 1, 1984
Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acidsT Wessel-Aas, J P Blomhoff, E Wirum, et al.
Acta Pharmacologica Et Toxicologica|March 1, 1985
The influence of sustained release theophylline therapy on free fatty acids in serumR A Walstad, K I Myhre, E Wirum, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Labetalol in the treatment of hypertension in patients with normal and impaired renal functionR A Walstad, K J Berg, T Wessel-Aas, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysisT E Wideröe, L C Smeby, O L Myking, et al.
Acta Medica Scandinavica|January 1, 1984
Toxicity of plasma from hemodialysis patients treated with heparin or prostacyclinT Wessel-Aas, K J Berg, T E Widerøe, et al.
Acta Medica Scandinavica|January 1, 1984
The effect of systemic heparinization on plasma lipoproteins and toxicity in patients on hemodialysis and continuous ambulatory peritoneal dialysisT Wessel-Aas, J P Blomhoff, T E Widerøe, et al.
Pageof 3